Post by Biogen on X
Biogen@biogen
X#News: We announced topline results from a Phase 2 study for an investigational drug targeting tau in individuals with early Alzheimer’s disease. These results represent an important milestone for the field. Learn more: t.co
10 likes0 repliesPosted May 14, 2026